EMAIL THIS PAGE TO A FRIEND

Urologiia (Moscow, Russia : 1999)

[Overactive bladder as a mask of chronic prostatitis].


PMID 23379238

Abstract

In order to investigate the frequency of symptoms of overactive bladder (OAB) in patients with chronic prostatitis and determine the effectiveness of trospium chloride in their treatment, the analysis of case histories of 154 patients referred to a urologist for the exacerbation of chronic prostatitis was performed. 27 (17.5%) patients had a diagnosis of overactive bladder; in 19 patients it was accompanied by chronic prostatitis, and in 8 patients OAB was diagnosed as separate disease. All of them have received trospium chloride 30 mg once daily for a month; patients with prostatitis simultaneously have received standard etiopathogenic therapy for this disease. A month later, a comprehensive treatment led to significant positive effect. Urinary frequency decreased by 56.1%, the functional bladder capacity increased by 82.8%, the number of urgent vesical tenesmus was reduced more than by half.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

Y0000429 Trospium chloride, European Pharmacopoeia (EP) Reference Standard
C25H30ClNO3